Home / Markets / News / Dr Reddy's Labs advances 4%, hits a record high on healthy Q1 numbers

Dr Reddy's Labs advances 4%, hits a record high on healthy Q1 numbers

The company's consolidated revenues rose 15 per cent to Rs 4,418 crore, mainly due to growth in US formulations

Premium

Analysts on an average had expected a profit of Rs 496 crore on revenues of Rs 4,170 crore for the quarter.

2 min read Last Updated : Jul 29 2020 | 2:28 PM IST

Shares of Dr Reddy’s Laboratories hit a record high of Rs 4,224, up 4 per cent on the BSE on Wednesday after the company reported a better-than-expected net profit of Rs 579 crore in April-June quarter (Q1FY21), on the back of strong revenue growth. The pharmaceutical company had posted a profit of Rs 663 crore in the year-ago period. The stock surpassed its previous high of Rs 4189.35, touched on June 10, 2020.

The company’s consolidated revenues rose 15 per cent to Rs 4,418 crore, mainly due to growth in US formulations driven by currency tailwinds and strong traction from

Topics : Dr Reddy's Labs Buzzing stocks Markets Sensex Nifty Q1 results corporate earnings

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in